WO2004018701A3 - Structures haplotypes du chromosome 21 - Google Patents

Structures haplotypes du chromosome 21 Download PDF

Info

Publication number
WO2004018701A3
WO2004018701A3 PCT/US2003/026469 US0326469W WO2004018701A3 WO 2004018701 A3 WO2004018701 A3 WO 2004018701A3 US 0326469 W US0326469 W US 0326469W WO 2004018701 A3 WO2004018701 A3 WO 2004018701A3
Authority
WO
WIPO (PCT)
Prior art keywords
chromosome
snp haplotype
haplotype structures
haplotype
structures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/026469
Other languages
English (en)
Other versions
WO2004018701A2 (fr
Inventor
David R Cox
Deana A Arnold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perlegen Sciences Inc
Original Assignee
Perlegen Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/227,152 external-priority patent/US20040053232A1/en
Priority claimed from US10/227,195 external-priority patent/US7115726B2/en
Application filed by Perlegen Sciences Inc filed Critical Perlegen Sciences Inc
Priority to AU2003269993A priority Critical patent/AU2003269993A1/en
Publication of WO2004018701A2 publication Critical patent/WO2004018701A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004018701A3 publication Critical patent/WO2004018701A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'un des polymorphismes, quel qu'il soit, de blocs d'haplotypes SNP ou de motifs d'haplotypes SNP (polymorphisme d'un seul nucléotide). Dans un mode de réalisation, on évalue la sensibilité à un phénotype résultant d'un allèle ou d'un marqueur dans un déséquilibre de liaison avec lesdites formes polymorphes. Des nouveaux composés thérapeutiques et diagnostiques ainsi que des procédés sont décrits.
PCT/US2003/026469 2002-08-22 2003-08-22 Structures haplotypes du chromosome 21 Ceased WO2004018701A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003269993A AU2003269993A1 (en) 2002-08-22 2003-08-22 Haplotype structures of chromosome 21

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/227,152 US20040053232A1 (en) 2001-10-05 2002-08-22 Haplotype structures of chromosome 21
US10/227,195 US7115726B2 (en) 2001-03-30 2002-08-22 Haplotype structures of chromosome 21
US10/227,152 2002-08-22
US10/227,195 2002-08-22

Publications (2)

Publication Number Publication Date
WO2004018701A2 WO2004018701A2 (fr) 2004-03-04
WO2004018701A3 true WO2004018701A3 (fr) 2005-03-17

Family

ID=31949792

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026469 Ceased WO2004018701A2 (fr) 2002-08-22 2003-08-22 Structures haplotypes du chromosome 21

Country Status (2)

Country Link
AU (1) AU2003269993A1 (fr)
WO (1) WO2004018701A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468248B2 (en) 2002-12-31 2008-12-23 Cargill, Incorporated Methods and systems for inferring bovine traits
EP1637612A1 (fr) * 2004-09-10 2006-03-22 Sanofi-Aventis Deutschland GmbH Association de polymorphismes d'un protéine avec maladie du coeur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 20 July 2000 (2000-07-20), NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA): "Entrez database nucleotide sequences", XP002984516, accession no. NCBI Database accession no. NT-002836, GI: 8134249 *

Also Published As

Publication number Publication date
WO2004018701A2 (fr) 2004-03-04
AU2003269993A8 (en) 2004-03-11
AU2003269993A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
WO2006063704A3 (fr) Polymorphisme a simple nucleotide (snp)
SG142154A1 (en) Methods for genomic analysis
WO2008033461A3 (fr) Procédés pour l'identification, l'évaluation et le traitement de patients ayant des troubles à médiation par le récepteur 2 de la chimiokine cc (ccr-2)
WO2002062825A3 (fr) Detection de polymorphismes dans le gene humain de la 5-lipoxygenase
WO2004018701A3 (fr) Structures haplotypes du chromosome 21
WO2006099259A3 (fr) Nouvelles mutations faux-sens et polymorphismes a simple nucleotide dans le gene du type rabphillin-3a et utilisations correspondantes
AU2002364945A8 (en) Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
AU2003276427A8 (en) Genetic markers on chromosome 12 associated to bipolar or unipolar disorders
WO2003031651A3 (fr) Maladie intestinale inflammatoire
WO2007006862A3 (fr) Methode et trousse permettant de detecter un risque de coronaropathie
WO2004081191A3 (fr) Haplotypage moleculaire d'adn genomique
WO2003064600A3 (fr) Batterie de genes d'il-1 et polymorphismes et haplotypes inflammatoires associes
WO2005112568A3 (fr) Marqueurs haplotypes et procedes d'utilisation de ceux-ci pour determiner la reponse a un traitement
WO2004005886A3 (fr) Kits et procedes pour evaluer la sante cardio-vasculaire
WO2006063703A3 (fr) Polymorphisme a simple nucleotide (snp)
WO2002080755A3 (fr) Trousses et methodes permettant d'evaluer le stress oxydatif
AU2002358580A1 (en) Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
WO2003022875A3 (fr) Polymorphismes de pd-1
WO2001023410A3 (fr) Isogenes cibles a usage medicamenteux: polymorphismes dans le gene d'interleukine
WO2006053955A3 (fr) Procede et kit de detection d'un risque d'hypertension arterielle essentielle
WO2005052180A3 (fr) Marqueurs genetiques de ntrk1 associes a l'evolution de la maladie d'alzheimer
WO2004005534A3 (fr) Criblages relatifs a la maladie d'alzheimer
WO2005037204A3 (fr) Marqueurs genetiques de ntrk1 associes a l'apparition de la maladie d'alzheimer
WO2005042706A3 (fr) Marqueurs genetiques ephx2 associes a la reaction a la galantamine
WO2003101377A3 (fr) Association des polymorphismes mononucleotidiques dans le locus dgcr2 et les locus voisins avec la schizophrenie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP